title: Can MGMT promoter methylation status be used as a prognostic and predictive marker for glioblastoma multiforme at the present time? A word of caution.
authors.affiliation: Klinik für Strahlentherapie, Universitätsstr. 27, 91054, Erlangen, Germany, sekretariat.strahlenklinik@uk-erlangen.de.
authors.forename: R
authors.initials: R
authors.lastname: Fietkau
authors.forename: F
authors.initials: F
authors.lastname: Putz
authors.forename: G
authors.initials: G
authors.lastname: Lahmer
authors.forename: S
authors.initials: S
authors.lastname: Semrau
authors.forename: R
authors.initials: R
authors.lastname: Buslei
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D018899:CpG Islands / Q000235:genetics; D019175:DNA Methylation / Q000235:genetics*; D015254:DNA Modification Methylases / Q000235:genetics*; D045643:DNA Repair Enzymes / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005909:Glioblastoma / Q000175:diagnosis* / Q000235:genetics*; D006801:Humans; D011379:Prognosis; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D005819:Genetic Markers; D025521:Tumor Suppressor Proteins; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D045643:DNA Repair Enzymes